Therapy of chronic delta hepatitis with alpha- and beta-interferon.
Gaudin
J L
JL
Department of HepatoGastroEnterology, Hotel-Dieu Hospital, Lyon, France.
Trépo
C
C
D000956:Antigens, Viral / Q000032:analysis; D006508:Hepatitis Antibodies / Q000097:blood; D003699:Hepatitis D / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D003698:Hepatitis Delta Virus / Q000276:immunology; D035923:Hepatitis delta Antigens; D006521:Hepatitis, Chronic / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use*; D008099:Liver / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D011994:Recombinant Proteins
D000956:Antigens, Viral; D006508:Hepatitis Antibodies; D035923:Hepatitis delta Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; C442244:hepatitis delta virus large antigen; D016899:Interferon-beta